End-to‑end solutions from target discovery to regulatory approval. We accelerate your pipeline with cutting‑edge chemistry, biology, and formulation expertise.
From early discovery through clinical development and regulatory filing – we deliver at every stage.
CRISPR screens, proteomics, bioinformatics, and functional assays to identify and validate novel drug targets.
Medicinal chemistry, SAR, in vitro ADME, and efficacy studies to advance hit compounds.
GLP toxicology, pharmacokinetics, safety pharmacology, and animal efficacy models.
Pre‑formulation, lipid nanoparticles, lyophilization, and stability studies for small & large molecules.
Phase I‑IV biostatistics, monitoring, data management, and medical writing.
IND/NDA preparation, agency meeting support, and post‑approval submissions (FDA, EMA, PMDA).
A seamless, stage‑gate approach designed to reduce risk and accelerate timelines.
Accelerated development paths
GLP/GMP compliant
Former industry & regulators
Multi‑region submissions
Our pharmaceutical R&D experts are ready to discuss your molecule or program. Receive a confidential proposal within 5 business days.
